John E. Godwin
- Hematology top 0.2%
- Acute Myeloid Leukemia Research 59
- Chronic Myeloid Leukemia Treatments 13
- Multiple Myeloma Research and Treatments 10
- Genetics top 1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 13
- Chronic Lymphocytic Leukemia Research 10
- Oncology top 2%
- CAR-T cell therapy research 19
- Molecular Biology top 5%
- Histone Deacetylase Inhibitors Research 12
-
- Lymphoma Diagnosis and Treatment 12
- Co-authors
- Frederick R. AppelbaumCheryl L. WillmanDavid R. HeadMarilyn L. SlovakStephen H. PetersdorfJeanne E. AndersonKenneth J. KopeckyHolly Gundacker
- Cited by
- HematologyGeneticsOncology
- Journals
- Blood (40 papers)Journal of Clinical Oncology (12 papers)American Journal of Hematology (5 papers)
- Partner nations
- United StatesFranceIsrael
In The Last Decade
John E. Godwin
107 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Hematology 2.6k
- Genetics 764
- Oncology 1.3k
- Public Health, Environmental and Occupational Health 922
- Molecular Biology 1.6k
Countries citing papers authored by John E. Godwin
This map shows the geographic impact of John E. Godwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Godwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Godwin more than expected).
Fields of papers citing papers by John E. Godwin
This network shows the impact of papers produced by John E. Godwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Godwin. The network helps show where John E. Godwin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John E. Godwin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2021 | 1 | |
| 4 | 2020 | 3 | |
| 5 | 2019 | 1 | |
| 6 | 2019 | 24 | |
| 7 | 2018 | 4 | |
| 8 | 2017 | 1 | |
| 9 | 2017 | 10 | |
| 10 | 2016 | 9 | |
| 11 | 2015 | 96 | |
| 12 | 2012 | 42 | |
| 13 | 2008 | 46 | |
| 14 | 2000 | 14 | |
| 15 | 1999 | 4 | |
| 16 | 1996 | 2 | |
| 17 | 1996 | 91 | |
| 18 | 1993 | 35 | |
| 19 | 1991 | 26 | |
| 20 | 1988 | 75 |
About John E. Godwin
John E. Godwin is a scholar working on Hematology, Genetics and Oncology, having authored 110 papers that have together received 4.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (59 papers), CAR-T cell therapy research (19 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers), Chronic Myeloid Leukemia Treatments (13 papers), Histone Deacetylase Inhibitors Research (12 papers), Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Multiple Myeloma Research and Treatments (10 papers). The work is most often cited by research in Hematology (2.6k citations), Genetics (764 citations) and Oncology (1.3k citations). John E. Godwin has collaborated with scholars based in United States, France and Israel. Frequent co-authors include Frederick R. Appelbaum, Cheryl L. Willman, David R. Head, Marilyn L. Slovak, Stephen H. Petersdorf, Jeanne E. Anderson, Kenneth J. Kopecky, Holly Gundacker, Catherine P. Leith and Sucha Nand. Their work appears in journals such as Blood, Journal of Clinical Oncology, American Journal of Hematology, Cancer and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.